Tariffs Threaten Global Drug Supply Chains
Reading Time : 2 minutes Trump’s new 25% tariffs on pharmaceuticals aim to boost U.S. manufacturing. The move could reshape global drug supply chains and spark retaliation. Major exporters like Ireland, China, and Germany may face steep losses. Consumers in the U.S. could see rising prices.